Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to β-blockers: A double-blind, placebo-controlled, randomized-trial.
Alvarado-Tapias E, Brujats A, Puente A, Ardevol A, Rodriguez-Arias A, Fajardo J, Pavel O, Garcia-Guix M, Aracil C, Poca M, Cuyàs B, Cantó E, Montañés R, Garcia-Osuna A, Escorsell À, Torras X, Villanueva C. Alvarado-Tapias E, et al. Among authors: brujats a. Hepatology. 2024 Nov 7. doi: 10.1097/HEP.0000000000001148. Online ahead of print. Hepatology. 2024. PMID: 39509369
Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial.
Dajti E, Villanueva C, Berzigotti A, Brujats A, Albillos A, Genescà J, García-Pagán JC, Colecchia A, Bosch J; PREDESCI trial investigators; A study by the Baveno Cooperation, an EASL Consortium. Dajti E, et al. Among authors: brujats a. J Hepatol. 2024 Sep 19:S0168-8278(24)02553-4. doi: 10.1016/j.jhep.2024.09.014. Online ahead of print. J Hepatol. 2024. PMID: 39303875 Free article.
Binge drinking at time of bariatric surgery is associated with liver disease, suicides, and increases long-term mortality.
Alvarado-Tapias E, Martí-Aguado D, Gómez-Medina C, Ferrero-Gregori A, Szafranska J, Brujats A, Osuna-Gómez R, Guinart-Cuadra A, Alfaro-Cervelló C, Pose E, Ventura-Cots M, Clemente A, Fernández-Carrillo C, Contreras C, Cabezas J, López-Pelayo H, Arab JP, Argemi J, Bataller R. Alvarado-Tapias E, et al. Among authors: brujats a. Hepatol Commun. 2024 Jul 22;8(8):e0490. doi: 10.1097/HC9.0000000000000490. eCollection 2024 Aug 1. Hepatol Commun. 2024. PMID: 39037383 Free PMC article.
Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes.
Garcia-Guix M, Ardevol A, Sapena V, Alvarado-Tápias E, Huertas A, Brujats A, Fajardo J, Cuyas B, Poca M, Guarner C, Torras X, Escorsell À, Villanueva C. Garcia-Guix M, et al. Among authors: brujats a. Liver Int. 2024 Aug;44(8):1971-1989. doi: 10.1111/liv.15937. Epub 2024 Apr 18. Liver Int. 2024. PMID: 38634685
Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data.
Villanueva C, Sapena V, Lo GH, Seo YS, Shah HA, Singh V, Tripathi D, Schepke M, Gheorghe C, Bonilha DQ, Jutabha R, Wang HM, Rodrigues SG, Brujats A, Lee HA, Azam Z, Kumar P, Hayes PC, Sauerbruch T, Chen WC, Iacob S, Libera ED, Jensen DM, Alvarado E, Torres F, Bosch J; Baveno Cooperation-a EASL Consortium. Villanueva C, et al. Among authors: brujats a. Aliment Pharmacol Ther. 2024 Feb;59(3):306-321. doi: 10.1111/apt.17824. Epub 2023 Dec 18. Aliment Pharmacol Ther. 2024. PMID: 38108646 Review.
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis.
Reiniš J, Petrenko O, Simbrunner B, Hofer BS, Schepis F, Scoppettuolo M, Saltini D, Indulti F, Guasconi T, Albillos A, Téllez L, Villanueva C, Brujats A, Garcia-Pagan JC, Perez-Campuzano V, Hernández-Gea V, Rautou PE, Moga L, Vanwolleghem T, Kwanten WJ, Francque S, Trebicka J, Gu W, Ferstl PG, Gluud LL, Bendtsen F, Møller S, Kubicek S, Mandorfer M, Reiberger T. Reiniš J, et al. Among authors: brujats a. J Hepatol. 2023 Feb;78(2):390-400. doi: 10.1016/j.jhep.2022.09.012. Epub 2022 Sep 22. J Hepatol. 2023. PMID: 36152767 Free article.
Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis.
Villanueva C, Torres F, Sarin SK, Shah HA, Tripathi D, Brujats A, Rodrigues SG, Bhardwaj A, Azam Z, Hayes PC, Jindal A, Abid S, Alvarado E, Bosch J; Carvedilol-IPD-MA-group and the Baveno Cooperation: an EASL Consortium. Villanueva C, et al. Among authors: brujats a. J Hepatol. 2022 Oct;77(4):1014-1025. doi: 10.1016/j.jhep.2022.05.021. Epub 2022 May 31. J Hepatol. 2022. PMID: 35661713 Free article.
15 results